Pam Belluck, a health and science writer for The New York Times, shares her insights on the evolving landscape of abortion rights in America. She discusses the optimistic push from anti-abortion activists to overturn Roe v. Wade, while abortion rights advocates anticipate potential changes in FDA regulations regarding mifepristone. The conversation highlights the rise of medication abortion, the role of telemedicine during the pandemic, and the complexities of accessing these services in various states, shedding light on ongoing public debates.
